Emblica Bio Private Limited
About Emblica Bio Private Limited
Data last updated:
Emblica Bio Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 28 January 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2022PTC392979.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archana Agarwal and Raju Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 611 Ganapati Apartment Dwarka Sector 9, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹75.68 Lakh, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹12.85 Lakh (net margin 17%) and EBITDA of ₹13.3 Lakh (EBITDA margin 17.6%). Revenue has grown at a compounded annual rate (CAGR) of 294% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address611 Ganapati Apartment Dwarka Sector 9, Delhi, India – 110075
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emblica Bio Private Limited
The main business activity of Emblica Bio is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emblica Bio Private Limited FY 2025 filings available
Emblica Bio Private Limited reported revenue of ₹75.68 Lakh (up 61% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Emblica Bio Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 294% over three years, including 61% growth in the latest year. EBITDA rose 170% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emblica Bio Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.3 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.85 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Emblica Bio Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 17.6% | •••• | •••• | •••• |
| Net Profit Margin | 17% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emblica Bio are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emblica Bio Private Limited
Emblica Bio Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Metabalance Healthcare Private Limited | ₹76.02 Lakh (FY 2025) | •••• | •••• | 90.0% | •••• | Gurgaon, Haryana, India |
| SSDC Implant Centre Private Limited | ₹76.02 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Om Nath Hospital Private Limited | ₹75.88 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Noida, Uttar Pradesh, India |
| Maatulya Diagnostics Center Private Limited | ₹75.74 Lakh (FY 2025) | •••• | •••• | 99.0% | •••• | Hyderabad, Telangana, India |
| Dart Seva Healthline Services Private Limited | ₹75.71 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Bangalore, Karnataka, India |
| Emblica Bio Private Limited this company | ₹75.68 Lakh (FY 2025) | •••• | •••• | 61.0% | •••• | Delhi, India |
| Pooja Ambulance Services Private Limited | ₹75.6 Lakh (FY 2024) | •••• | •••• | 28.0% | •••• | Faridabad, Haryana, India |
| Mahavir Healthcare Institutions Dahod Private Limited | ₹75.53 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Dahod, Gujarat, India |
| New Horizons Healthcare Private Limited | ₹75.45 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Navoday Clinic Private Limited | ₹75.35 Lakh (FY 2022) | •••• | •••• | 107.0% | •••• | Ahmednagar, Maharashtra, India |
| Srirama Lakshmi Healthcare Private Limited | ₹75.25 Lakh (FY 2025) | •••• | •••• | -62.0% | •••• | Tadepalligudem, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Emblica Bio by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Emblica Bio Private Limited
Emblica Bio Private Limited is audited by Praveen Shri Niwas & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Praveen Shri Niwas & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Emblica Bio Private Limited
Emblica Bio has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Agarwal | Director | 28 Jan 2022 | 4 Years 8 Months | Current |
| Raju Agarwal | Director | 28 Jan 2022 | 4 Years 8 Months | Current |
Ownership and Shareholding of Emblica Bio Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emblica Bio Private Limited
Emblica Bio Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Emblica Bio Private Limited
Emblica Bio Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emblica Bio Private Limited
Emblica Bio Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Archana Agarwal was appointed as Director on 28 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for Emblica Bio Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emblica Bio Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emblica Bio Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emblica Bio Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emblica Bio Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emblica Bio Private Limited
Emblica Bio is an active private limited company based in Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 28 January 2022 (4+ years old) and is registered under CIN U85100DL2022PTC392979.
Emblica Bio reported revenue of ₹75.68 Lakh for FY 2025 (up 61% YoY).
Emblica Bio has 2 current directors:
- Archana Agarwal - Director
- Raju Agarwal - Director
Emblica Bio reported a net profit of ₹12.85 Lakh (net margin 17%) and EBITDA of ₹13.3 Lakh (EBITDA margin 17.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emblica Bio is 294% over three years. In the latest year (FY 2025) revenue rose 61%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Emblica Bio is U85100DL2022PTC392979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emblica Bio was incorporated on 28 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Emblica Bio by revenue are Metabalance Healthcare Private Limited, SSDC Implant Centre Private Limited, Om Nath Hospital Private Limited, Maatulya Diagnostics Center Private Limited, Dart Seva Healthline Services Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Archana Agarwal was appointed as Director on 28 Jan 2022. Raju Agarwal was appointed as Director on 28 Jan 2022.
Yes, Emblica Bio is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Emblica Bio is at 611 Ganapati Apartment Dwarka Sector 9, Delhi, India – 110075.